Categories: News

Beyond Medical Technologies Inc. Announces Management Changes and New Appointment of Daniel Liu as Chief Executive Officer and Director

Vancouver, British Columbia–(Newsfile Corp. – February 3, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) is pleased to announce that it has appointed Daniel Liu as Chief Executive Officer and as a director of the Company. Mr. Liu replaces Kal Malhi in these roles, following Mr. Malhi’s resignation as Chief Executive Officer and as a director, effective January 30, 2025.

Mr Malhi leaves Beyond Medical to pursue other ventures but will remain available to consult for the Company as required. The Company would like to thank Mr. Malhi for his service and wishes him the best in his future endeavors.

On behalf of the Board of Directors

“Daniel Liu” Chief Executive Officer
Email: danzliu94@gmail.com
https://beyond-md.ca/

Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239500

Staff

Recent Posts

Restart Life Sciences Announces Closing First Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

47 minutes ago

TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

47 minutes ago

Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 5, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced…

47 minutes ago

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

6 hours ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

6 hours ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

6 hours ago